---
title: "Cohance Lifesciences Ltd (COHANCE) — Share Price, Financials & Analysis"
symbol: "COHANCE"
company: "Cohance Lifesciences Ltd"
canonical: "https://tapetide.com/stocks/COHANCE"
isin: "INE03QK01018"
nse_symbol: "COHANCE"
bse_code: "543064"
sector: "Healthcare"
industry: "Pharmaceuticals"
market_cap_cr: 16706.71
generated_at: "2026-09-13T19:41:08.657Z"
---

# Cohance Lifesciences Ltd (COHANCE)

Canonical page: https://tapetide.com/stocks/COHANCE

## Company

- **NSE Symbol:** COHANCE
- **BSE Code:** 543064
- **ISIN:** INE03QK01018
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2020-03-09
- **CEO:** Mr. Vivek Sharma CPA
- **Employees:** 1212
- **Face Value:** ₹1
- **F&O Eligible:** No
- **Website:** cohance.com

## About

Cohance Lifesciences is a Hyderabad-based CDMO operating across pharmaceutical development, manufacturing, APIs, formulations and specialty chemicals. The company states that it features among the Top 20 CDMOs globally; its Pharma CDMO business works with 19 of the top 20 global innovators, while the API portfolio ranks among the top three suppliers in 8 of its top 10 molecules.[1][2]

## Latest Price

- **Price:** ₹440.2
- **Change:** -5.1 (-1.15%)
- **Open:** ₹445.2
- **Day High:** ₹445.2
- **Day Low:** ₹434.15
- **Previous Close:** ₹445.3
- **Volume:** 468144
- **As Of:** 2026-09-11T10:26:20+00:00

## Key Fundamentals

Observed at 2026-09-11T04:53:01.102706Z.

- **Market Cap:** ₹16706.71 Cr
- **Classification:** Smallcap
- **P/E (reported):** 291.3
- **P/E (TTM):** 158.35
- **EPS (TTM):** ₹2.78
- **EPS (reported):** ₹9.45
- **Book Value:** ₹102.23
- **Price to Book:** 4.36
- **Dividend Yield:** 1.35%
- **ROE:** 3.72%
- **ROCE:** 4.81%
- **Debt to Equity:** 0.1
- **Revenue (yearly):** ₹2302.6 Cr
- **Net Income:** ₹150.1 Cr
- **EBITDA:** ₹461.1 Cr
- **52-Week High:** ₹1020.7
- **52-Week Low:** ₹266.7
- **RSI (14):** 47.5

## Tapetide Score

- **Score:** 39 / 100
- **Score date:** 2026-09-04
- **Archetype:** Trend Ahead of Fundamentals
- **What it means:** The price trend is running ahead of what the financials currently support. Moves like this depend on the fundamentals catching up; check what would have to be true for that.
- **Pillar profile:** Quality: Average · Valuation: Expensive · Momentum: Rising
- **Percentile:** 12 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 39.44 | 9% |
| growth | 2.43 | 9% |
| momentum | 64.6 | 12% |
| ownership | 47.89 | 24% |
| quality | 58.74 | 22% |
| valuation | 36.01 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Weaknesses

- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 10.6% over last 3 years.
- Promoters have pledged 94.6% of their holding.
- Debtor days have increased from 88.0 to 110 days.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | -45.3% | 2.74% | 11.61% |
| ebitda margin growth | -83.31% | -38.11% | -52.34% | -57.91% |
| net income growth | -644.58% | -69% | -23% | -12% |
| revenue growth | -29.61% | -14.01% | 19% | 18% |
| roce | -224.16% | -66.41% | -75% | 22.25% |
| roe | -643.8% | -70.87% | 10.38% | -87.48% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 231 | 220 | 253 | 488 | 604 | 676 | 840 | 549 | 556 | 545 | 619 | 422 |
| Expenses | 133 | 154 | 180 | 363 | 398 | 439 | 611 | 437 | 435 | 449 | 520 | 421 |
| Operating Profit | 98 | 66 | 73 | 125 | 205 | 237 | 229 | 112 | 121 | 95 | 99 | 1 |
| OPM % | 42 | 30 | 29 | 26 | 34 | 35 | 27 | 20 | 22 | 18 | 16 | 0.3 |
| Other Income | 20 | 14 | 17 | 19 | 16 | 22 | -4 | 6 | 16 | 1 | -18 | 12 |
| Interest | 0 | 2 | 2 | 10 | 10 | 11 | 10 | 10 | 9 | 9 | 9 | 7 |
| Depreciation | 12 | 13 | 17 | 31 | 38 | 44 | 54 | 45 | 44 | 47 | 51 | 50 |
| Profit before tax | 105 | 65 | 71 | 103 | 174 | 205 | 161 | 63 | 84 | 41 | 20 | -43 |
| Tax % | 25 | 29 | 25 | 27 | 21 | 25 | 27 | 26 | 21 | 29 | 58 | 5 |
| Net Profit | 80 | 47 | 53 | 75 | 138 | 153 | 117 | 46 | 66 | 29 | 8 | -45 |
| EPS in Rs | 3.13 | 1.84 | 2.1 | 2.96 | 5.44 | 6.01 | 4.73 | 1.28 | 1.94 | 0.96 | 0.51 | -0.63 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 378 | 834 | 1010 | 1320 | 1340 | 1051 | 2608 | 2269 | 2142 |
| Expenses | 206 | 449 | 567 | 738 | 766 | 645 | 1811 | 1841 | 1825 |
| Operating Profit | 172 | 385 | 443 | 582 | 574 | 406 | 797 | 427 | 316 |
| OPM % | 45 | 46 | 44 | 44 | 43 | 39 | 31 | 19 | 15 |
| Other Income | 1 | 66 | 68 | 133 | 46 | 62 | 53 | 4 | 11 |
| Interest | 3 | 23 | 12 | 9 | 13 | 7 | 41 | 37 | 34 |
| Depreciation | 12 | 24 | 32 | 39 | 48 | 55 | 167 | 187 | 192 |
| Profit before tax | 158 | 405 | 468 | 668 | 560 | 406 | 643 | 207 | 101 |
| Tax % | 31 | 22 | 23 | 32 | 27 | 26 | 25 | 27 | — |
| Net Profit | 109 | 317 | 362 | 454 | 411 | 300 | 484 | 150 | 59 |
| EPS in Rs | — | 12.45 | 14.23 | 17.83 | 16.16 | 11.8 | 19.14 | 4.68 | 2.78 |
| Dividend Payout % | 0 | 20 | 14 | 28 | 37 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 0 | 13 | 25 | 25 | 25 | 25 | 25 | 38 |
| Reserves | 578 | 832 | 1155 | 1502 | 1710 | 2025 | 3623 | 3873 |
| Borrowings | 83 | 186 | 143 | 97 | 70 | 65 | 486 | 400 |
| Other Liabilities | 123 | 142 | 151 | 205 | 160 | 138 | 1346 | 1415 |
| Total Liabilities | 783 | 1173 | 1474 | 1830 | 1966 | 2254 | 5480 | 5727 |
| Fixed Assets | 271 | 357 | 441 | 534 | 663 | 670 | 3107 | 3369 |
| CWIP | 111 | 102 | 96 | 30 | 165 | 179 | 334 | 178 |
| Investments | 7 | 338 | 542 | 598 | 536 | 904 | 337 | 529 |
| Other Assets | 394 | 376 | 395 | 667 | 601 | 501 | 1702 | 1652 |
| Total Assets | 783 | 1173 | 1474 | 1830 | 1966 | 2254 | 5480 | 5727 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 50 | 407 | 383 | 330 | 457 | 358 | 673 | 368 |
| Cash from Investing Activity | -65 | -413 | -311 | -136 | -195 | -362 | -388 | -251 |
| Cash from Financing Activity | 26 | 7 | -76 | -156 | -242 | -14 | -327 | -165 |
| Net Cash Flow | 11 | 1 | -5 | 37 | 20 | -18 | -42 | -48 |
| Free Cash Flow | -6 | 304 | 272 | 255 | 171 | 307 | 357 | 169 |
| CFO/OP | 49 | 128 | 111 | 88 | 105 | 115 | 107 | 102 |

### Ratios

| Item | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 142 | 51 | 37 | 65 | 30 | 46 | 108 | 110 |
| Inventory Days | 556 | 278 | 243 | 259 | 279 | 268 | 209 | 310 |
| Days Payable | 190 | 113 | 100 | 97 | 63 | 49 | 120 | 157 |
| Cash Conversion Cycle | 509 | 217 | 180 | 228 | 247 | 265 | 197 | 263 |
| Working Capital Days | 205 | 64 | 56 | 108 | 99 | 115 | 106 | 133 |
| ROCE % | — | 50 | 40 | 41 | 32 | 19 | 21 | 6 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 60% | 60% | 50.1% | 50.1% | 50.1% | 50.1% | 50.1% | 66.41% | 57.49% | 57.49% | 57.49% | 57.49% |
| FIIs | 10.01% | 10.14% | 9.54% | 9.8% | 10.7% | 10.84% | 11.05% | 7.23% | 6.51% | 6.02% | 5.59% | 6.5% |
| DIIs | 14.14% | 15.94% | 17.24% | 17.42% | 16.94% | 16.68% | 16.6% | 11.4% | 20.82% | 21.57% | 21.79% | 20.09% |
| Government | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% |
| Public | 11.76% | 10.87% | 10.51% | 10.08% | 9.75% | 9.81% | 9.68% | 6.4% | 6.42% | 6.76% | 7.04% | 7.71% |
| Others | 4.08% | 3.04% | 12.59% | 12.59% | 12.5% | 12.56% | 12.55% | 8.55% | 8.75% | 8.16% | 8.08% | 8.21% |
| No. of Shareholders | 73715 | 70052 | 68932 | 65777 | 69337 | 84210 | 86325 | 80910 | 75284 | 81877 | 85230 | 99149 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 5 / 3 / 11

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 452.17 | Sell |
| EMA (10) | 449.12 | Sell |
| SMA (20) | 453.37 | Sell |
| EMA (20) | 449.81 | Sell |
| SMA (50) | 444.12 | Sell |
| EMA (50) | 444.48 | Sell |
| SMA (100) | 441.1 | Sell |
| EMA (100) | 441.99 | Sell |
| SMA (200) | 423.06 | Buy |
| EMA (200) | 503.75 | Sell |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 44.84 | Neutral |
| MACD (12,26,9) | 0.59 | Sell |
| Stochastic (14,3,3) | 17.54 | Buy |
| ADX (14) | 37.32 | Buy |
| Williams %R (14) | -85.71 | Buy |
| ATR (14) | 15.89 | High Volatility |
| ROC (12) | -4.79 | Sell |
| Stoch RSI (14) | 0 | Buy |
| UO (7,14,28) | 38.31 | Neutral |

## Analyst Ratings

| Recommendation | Analysts | Share |
| --- | --- | --- |
| Buy | 3 | 37.5% |
| Hold | 1 | 12.5% |
| Sell | 4 | 50% |

Based on 8 analyst ratings, observed at 2026-09-11T04:53:01.307179+00:00.

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-05 | [Completion Of USFDA Inspection](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9419d34f-c8a6-4e64-93f5-a5dd40c9264b.pdf) |
| 2026-09-03 | [Board Meeting Outcome for Outcome Of The Committee Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4ce15234-2524-46fe-baf5-22174155050f.pdf) |
| 2026-09-03 | [Announcement under Regulation 30 (LODR)-Press Release / Media Release](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=628560b4-24d4-4ed3-9290-628badf88ddf.pdf) |
| 2026-08-27 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0ca7e056-f11d-41c7-8bd1-ac294f2e0efd.pdf) |
| 2026-08-27 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f48ba4e4-7f71-4b81-89d5-aa684f8afa05.pdf) |
| 2026-08-26 | [Notice Of AGM 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d4ba1801-933e-402b-a65a-9d7a6034f83f.pdf) |
| 2026-08-26 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=57785e14-bc4d-4ed1-979b-86c824dcebcd.pdf) |
| 2026-08-26 | [Business Responsibility and Sustainability Reporting (BRSR)](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d9597425-7413-4027-8906-5c3bc248d83d.pdf) |
| 2026-08-13 | [Announcement under Regulation 30 (LODR)-Credit Rating](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1847944b-afad-4fe2-aca2-5d3055a97f6c.pdf) |
| 2026-08-12 | [Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=928962EB_EC38_40BB_B0CA_23F7C96B9566_111006.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-05 | [Outcome Of The Board Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=78cbe2ab-9a8e-42c3-87f0-dd31191486af.pdf) |
| 2026-05-12 | [Outcome Of The Board Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=43652fb8-efba-455e-9cbd-757b3f823843.pdf) |
| 2026-02-12 | [Outcome Of Board Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0397614a-7158-46d8-b89a-ba9953de9bbe.pdf) |
| 2025-11-12 | [Outcome Of The Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2f2980fa-adb3-449f-9e81-839ea46ed7b1.pdf) |
| 2025-08-13 | [Outcome Of The Board Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=536f1fc9-8042-4b24-9b24-c52e2c8af247.pdf) |
| 2025-05-28 | [Financial Results For Period Ended March 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2455072f-609c-4850-a5c8-8f989d13f9c7.pdf) |
| 2024-08-09 | [Outcome Of The Board Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3705277e-aa34-44fa-b02e-5ecf56efe36e.pdf) |
| 2024-05-30 | [Outcome Of The Board Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bf4a23b1-90d5-4012-ba81-1f7235c6d0b4.pdf) |
| 2024-05-30 | [Outcome Of The Board Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4ff798d8-b0a0-4de6-bce6-b8aaf62e921b.pdf) |
| 2024-02-05 | [Outcome Of The Board Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=094c1d73-6e66-4ded-b61f-a62b37f753c2.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=af10d29e-7173-4207-9ccf-86a033601f6e.pdf) |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e151379c-afe1-4ba5-a005-6f08a84d0cf4.pdf) |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/af10d29e-7173-4207-9ccf-86a033601f6e.pdf) |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e151379c-afe1-4ba5-a005-6f08a84d0cf4.pdf) |
| Nov 2024 | [Concall - Nov 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2fa99890-a8ba-40ca-a67e-43efc369781a.pdf) |
| Nov 2023 | [Concall - Nov 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/cefee64d-9d8c-407b-a3c7-2c12b646f070.pdf) |
| Nov 2023 | [Concall - Nov 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9d400973-cd22-48bb-8500-90c6e2c829b9.pdf) |
| Nov 2022 | [Concall - Nov 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/cbd6b3d9-58bc-4007-9c28-282cb8e6c77e.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/05f9cfeb-8f32-4042-90c3-4db227f14e75.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachLive/05f9cfeb-8f32-4042-90c3-4db227f14e75.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 6 May - Schedule of Conference Call for Investors and analysts | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 6 May - Schedule of Conference Call for Investors and analysts](https://www.bseindia.com/xml-data/corpfiling/AttachLive/3744e591-9832-4973-bf08-40cac9cf57c4.pdf) |
| 6 May - Board meets May 12, 2026 to approve FY26 audited standalone and consolidated results; trading window closes until May 14. | [Board Meeting Intimation for To Consider And Approve The Audited Financial Results (Standalone And Consolidated) Of The Company, For The Quarter And Financial Year Ended March 31, 2026. 6 May - Board meets May 12, 2026 to approve FY26 audited standalone and consolidated results; trading window closes until May 14.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/517391be-d3c9-4527-80fc-941c8b5b5cc6.pdf) |
| 6 Mar - Management to attend Investec CDMO Day roadshow in Hyderabad on March 13, 2026. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 6 Mar - Management to attend Investec CDMO Day roadshow in Hyderabad on March 13, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/35429898-93ea-4da9-a7cd-91fc87c82c0d.pdf) |
| 5 Feb - Unaudited standalone/consolidated results for quarter and nine months ended 31-Dec-2025; appointed Padmaja Priyadarshini as independent director. | [Announcement under Regulation 30 (LODR)-Change in Management 5 Feb - Unaudited standalone/consolidated results for quarter and nine months ended 31-Dec-2025; appointed Padmaja Priyadarshini as independent director.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e379f555-aa2f-4c9f-8000-2766dc30c84e.pdf) |
| 5 Feb - Unaudited standalone and consolidated Q3/9M results for Dec 31, 2025; appointed Padmaja Priyadarshini B N. | [Board Meeting Outcome for Outcome Of Board Meeting 5 Feb - Unaudited standalone and consolidated Q3/9M results for Dec 31, 2025; appointed Padmaja Priyadarshini B N.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/acc25c0b-f921-46e3-af12-f4914efd9d86.pdf) |
| 30 Mar - Mr. Sisir K. Mishra appointed Company Secretary, Compliance Officer and KMP effective April 9, 2026. | [Appointment of Company Secretary and Compliance Officer 30 Mar - Mr. Sisir K. Mishra appointed Company Secretary, Compliance Officer and KMP effective April 9, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/13d3ded2-5d7a-4611-81ee-032bbab6a3c0.pdf) |
| 30 Apr - Company clarifies price movement and states no undisclosed information exists. | [Clarification On Movement In Price Of Equity Shares 30 Apr - Company clarifies price movement and states no undisclosed information exists.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/38808228-ee50-4d49-94ba-d2543fb21b6f.pdf) |
| 30 Apr - Company clarifies price movement and states no undisclosed information exists. | [Clarification On Movement In Price Of Equity Shares 30 Apr - Company clarifies price movement and states no undisclosed information exists.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/38808228-ee50-4d49-94ba-d2543fb21b6f.pdf) |
| 27 Jan - Board meeting Feb 5, 2026 to approve unaudited standalone/consolidated results for quarter and nine months ended Dec 31, 2025. | [Board Meeting Intimation for Consideration And Approval Of Un-Audited (Standalone & Consolidated) Financial Results Of The Company For The Quarter And Nine Months Ended December 31, 2025 27 Jan - Board meeting Feb 5, 2026 to approve unaudited standalone/consolidated results for quarter and nine months ended Dec 31, 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/75128bd6-1b5b-4f0c-b83e-0c6a21d7bbe1.pdf) |
| 27 Apr - Umang Vohra appointed Executive Chairman May 1 and Group CEO May 20, 2026; Vivek Sharma steps down. | [Announcement under Regulation 30 (LODR)-Press Release / Media Release 27 Apr - Umang Vohra appointed Executive Chairman May 1 and Group CEO May 20, 2026; Vivek Sharma steps down.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4a30f2dc-bb19-4cc2-8d5d-e7554ed1e314.pdf) |

### Earnings Call Transcripts

| Date | Document |
| --- | --- |
| 2026-05-15 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=05f9cfeb-8f32-4042-90c3-4db227f14e75.pdf) |
| 2025-08-19 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a5bb5a8f-229c-40b8-b3cb-c40f09a91bdb.pdf) |
| 2025-06-02 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=12e3bc92-c179-4924-b331-cd06f046178a.pdf) |
| 2025-02-18 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=654a8886-30e6-4ce7-be5d-dba4ae41cad4.pdf) |
| 2024-11-17 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b2bd328a-a01c-4ee6-a211-eeed80578b93.pdf) |
| 2024-08-14 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=82d83640-8d3c-485c-9e89-96dd51775921.pdf) |
| 2024-06-04 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2ac51a1f-5a6d-4b83-9800-30cd495dd609.pdf) |
| 2024-02-09 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bbf41c15-a395-4b00-99f1-32920e195521.pdf) |
| 2023-11-14 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9d400973-cd22-48bb-8500-90c6e2c829b9.pdf) |
| 2023-08-14 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e69c1b94-23c3-4cde-b4bf-0a7d538291cc.pdf) |

### Investor Presentations

| Date | Document |
| --- | --- |
| 2026-02-12 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=58387b0d-b3f2-43fd-9542-6c89585316cd.pdf) |
| 2025-11-12 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c6d703a0-9c33-483f-aad5-2a83e1acbde8.pdf) |
| 2025-05-28 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a15a7709-e546-47ca-9d16-727c2e444ba2.pdf) |
| 2025-02-12 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bb4be0eb-03d9-4792-a416-2d841ccee064.pdf) |
| 2025-01-15 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1b8256e9-3113-47df-be4b-acefc441005e.pdf) |
| 2024-12-07 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=433e8bee-aee8-4d2c-9c9a-df70fb1973d5.pdf) |
| 2024-11-12 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2fa99890-a8ba-40ca-a67e-43efc369781a.pdf) |
| 2024-06-13 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=339e9a96-294c-4343-92e9-8735f02b4a1f.pdf) |
| 2024-02-29 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=197c3ef9-292f-409f-a9ca-312f1c8b0e05.pdf) |
| 2024-02-05 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c83dda9b-803d-4f4e-89ba-86b4bee6c331.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/95288350-4921-470f-b5c3-0b540b626a1b.pdf) |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/defeb63a-a24f-499c-8e97-7f7e27fcffe1.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/fec80c4b-d2f3-496a-9e3b-d263ba26c9f7.pdf) |
| from bse | [Financial Year 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2e4ea06e-820e-4fdf-96d6-5f7038d49948.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d8a5776c-da4c-473b-b815-a99242494f9a.pdf) |
| from bse | [Financial Year 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/274b6179-0324-4a24-8c05-b000628bbc3f.pdf) |

### Earnings Call Recordings

| Date | Document |
| --- | --- |
| 2024-06-19 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=10e462a2-76e8-4280-a5f2-0ea9d1b0de0a.pdf) |
| 2024-05-31 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e2d551be-2c47-44d0-a0e9-a1940bbca4c5.pdf) |
| 2024-03-06 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=12ae0710-6bc9-4432-8117-327fc02011f1.pdf) |
| 2024-02-06 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5a399109-a325-49a8-8705-7c08e6316b84.pdf) |
| 2023-11-10 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=feb869a0-60d6-4b99-b90e-869db4b066e1.pdf) |
| 2023-08-11 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=09f429c5-368f-4eab-b28e-735d5e7f1054.pdf) |
| 2023-05-26 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bb33b498-b986-4884-a83b-f0e2bdeca36c.pdf) |
| 2023-02-07 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b192d874-a0a1-4357-b119-f82115004ea2.pdf) |
| 2022-12-27 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5fcdc361-7f90-462c-9a2c-97c8732ade44.pdf) |
| 2022-11-10 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e7a9022f-533c-4722-a9c0-83805b5d5b77.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:41:08.657Z.